Sands BE, Barnes EL, D'Haens G, Hisamatsu T, et al. Mirikizumab Long-Term Efficacy and Safety in Patients with Crohn's disease: Results from the VIVID-2 Open-Label Extension Trial. Clin Gastroenterol Hepatol 2026 Mar 5:S1542-3565(26)00155.
PMID: 41794217